Free Trial

Tristel (TSTL) Competitors

Tristel logo
GBX 360 -1.00 (-0.28%)
As of 12:46 PM Eastern

TSTL vs. AMS, BVC, SPEC, AKR, CNSL, ODX, CTEC, CSRT, SLN, and AMYT

Should you be buying Tristel stock or one of its competitors? The main competitors of Tristel include Advanced Medical Solutions Group (AMS), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Consort Medical plc (CSRT.L) (CSRT), Silence Therapeutics (SLN), and Amryt Pharma (AMYT). These companies are all part of the "medical" sector.

Tristel vs. Its Competitors

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£220.30M2.22£11.22M£0.045,437.48
Tristel£43.56M3.94£6.54M£0.132,790.70

Advanced Medical Solutions Group pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.0%. Tristel pays an annual dividend of GBX 0.14 per share and has a dividend yield of 0.0%. Advanced Medical Solutions Group pays out 62.4% of its earnings in the form of a dividend. Tristel pays out 104.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Tristel had 4 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 5 mentions for Tristel and 1 mentions for Advanced Medical Solutions Group. Tristel's average media sentiment score of 1.32 beat Advanced Medical Solutions Group's score of 0.94 indicating that Tristel is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Advanced Medical Solutions Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tristel
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Advanced Medical Solutions Group has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500.

Advanced Medical Solutions Group currently has a consensus price target of GBX 273.67, indicating a potential upside of 20.69%. Tristel has a consensus price target of GBX 400, indicating a potential upside of 11.11%. Given Advanced Medical Solutions Group's stronger consensus rating and higher probable upside, research analysts clearly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tristel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

33.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 37.8% of Tristel shares are owned by institutional investors. 4.1% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 21.1% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tristel has a net margin of 15.47% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.43% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group8.49% 4.57% 2.35%
Tristel 15.47%20.43%9.89%

Summary

Tristel beats Advanced Medical Solutions Group on 10 of the 18 factors compared between the two stocks.

Get Tristel News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSTL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TSTL vs. The Competition

MetricTristelMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£171.81M£2.76B£6.11B£2.59B
Dividend Yield3.90%2.04%5.73%5.32%
P/E Ratio2,790.70266.9864.834,418.40
Price / Sales3.9494.15608.74101,543.57
Price / Cash20.96146.5437.4627.90
Price / Book5.272.3712.428.24
Net Income£6.54M£99.80M£3.32B£5.89B
7 Day Performance-0.83%30.34%1.01%0.32%
1 Month Performance0.56%30.61%10.75%2.22%
1 Year Performance1.41%166.11%76.20%141.92%

Tristel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSTL
Tristel
1.0873 of 5 stars
GBX 360
-0.3%
GBX 400
+11.1%
-1.1%£171.81M£43.56M2,790.70208Positive News
Earnings Report
AMS
Advanced Medical Solutions Group
2.6143 of 5 stars
GBX 227
+2.5%
GBX 273.67
+20.6%
+12.3%£490.73M£220.30M5,443.6510
BVC
BATM Advanced Communications
N/AGBX 19.10
flat
N/A+2.8%£83.41M£118.82M-320.47980High Trading Volume
SPEC
INSPECS Group
N/AGBX 47.10
-2.9%
GBX 60
+27.4%
-21.9%£47.89M£195.28M-584.371,673Gap Up
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 2.81
+0.4%
N/A-23.6%£6.69M£8.33M401.713,200Gap Up
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
3.8761 of 5 stars
GBX 240
+0.4%
GBX 309.40
+28.9%
+6.6%£4.82B£2.36B2,264.1510,000
CSRT
Consort Medical plc (CSRT.L)
N/AN/AN/AN/A£504.60M£298.60M127.85N/A
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down

Related Companies and Tools


This page (LON:TSTL) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners